{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T07:40:04Z","timestamp":1722152404275},"reference-count":24,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2020,12,29]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>In the therapy of cancer, several treatments have been designed using nanomaterials, among which gold nanoparticles (AuNPs) have been featured as a promising antitumoral agent. Our research group has developed the synthesis of gold nanoparticles L-AuNPs and D-AuNPs stabilized with zwitterions of imidazolium (L-1 and D-1) derived from L-methionine and D-methionine. Because the stabilizer agent is chiral, we observed through circular dichroism that AuNPs also present chirality; such chirality as well as the fact that the stabilizing agent contains fragments of methionine and imidazolium that are commonly involved in biological processes, opens up the possibility that this system may have biological compatibility. Additionally, the presence of methionine in the stabilizing agent opens the application of this system as a possible antitumor agent because methionine is involved in methylation processes of molecules such as DNA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>The aim of this research is the evaluation of the antitumor activity of gold nanoparticles stabilized with zwitterions of imidazolium (L-AuNPs) derived from L-methionine in the model of BALB\/c mice with lymphoma L5178Y.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Taking as a parameter cell density, the evaluation of the inhibitory effect of L-AuNPs was carried out with a series of in vivo tests in BALB\/c type mice; three groups of five mice each were formed (Groups 1, 2 and 3); all mice were i.p. inoculated with the lymphoblast murine L5178Y. Group 1 consisted of mice without treatment. In the Groups 2 and 3 the mice were treated with L-AuNPs at 0.3 mg\/Kg on days 1, 7 and 14 by orally and intraperitonally respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>These results show low antitumor activity of these gold nanoparticles (L-NPsAu) but interestingly, the imidazolium stabilizing agent of gold nanoparticle (L-1) displayed promising antitumor activity. On the other hand, the enantiomer of L-1, (D-1) as well as asymmetric imidazole derivate from L-methionine (L-2), do not exhibit the same activity as L-1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The imidazolium stabilizing agent (L-1) displayed promising antitumor activity. Modifications in the structure of L-1 showed that, the stereochemistry (like D-1) and the presence of methionine fragments (like L-2) are determinants in the antitumor activity of this compound.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573406415666191206093754","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T13:31:06Z","timestamp":1575639066000},"page":"33-39","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antitumor Effect of Zwitterions of Imidazolium Derived from L-methionine in BALB\/c Mice with Lymphoma L5178Y"],"prefix":"10.2174","volume":"17","author":[{"given":"Karen C.","family":"Vargas-Castro","sequence":"first","affiliation":[{"name":"Departamento de Qu\u00edmica, Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Puebla P\u00e9rez","sequence":"additional","affiliation":[{"name":"Departamento de Farmacobiolog\u00eda; Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma I.","family":"Rangel-Salas","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge I.","family":"Delgado-Saucedo","sequence":"additional","affiliation":[{"name":"Departamento de Farmacobiolog\u00eda; Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 B.","family":"Pelayo-V\u00e1zquez","sequence":"additional","affiliation":[{"name":"Departamento de Ciencias B\u00e1sicas, Aplicadas e Ingenier\u00edas Centro Universitario de Tonal\u00e1, Universidad de Guadalajara, Av. Nuevo Perif\u00e9rico No. 555, Ejido San Jos\u00e9 Tatepozco C.P. 45425, Tonal\u00e1 Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvia","family":"Becerra-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Centro de Nanociencias y Micro y Nanotecnolog\u00edas, Instituto Polit\u00e9cnico Nacional, Unidad Profesional \"Adolfo L\u00f3pez Mateos\", Luis Enrique Erro S\/N, Zacatenco C. P. 07738, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A.","family":"Peregrina-Lucano","sequence":"additional","affiliation":[{"name":"Departamento de Farmacobiolog\u00eda; Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul R.","family":"Qui\u00f1onez-Lopez","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela J.","family":"Soltero-Reynoso","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Cortes-Llamas","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica, Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara, Blvd. Marcelino Garc\u00eda Barrag\u00e1n #1421, esq. Ol\u00edmpica, C.P. 44430 Guadalajara, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.4314\/tjpr.v13i7.23","volume":"13","author":"Khan A.","year":"2014","unstructured":"Khan A.; Rashid R.; Murtaza G.; Zahra A.; Trop J Pharm 2014,13(7),1169-1177","journal-title":"Trop J Pharm"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1021\/nn800507t","volume":"2","author":"Ghosh P.S.","year":"2008","unstructured":"Ghosh P.S.; Kim C.K.; Han G.; Forbes N.S.; Rotello V.M.; Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2008,2(11),2213-2218","journal-title":"ACS Nano"},{"key":"ref=3","first-page":"3","author":"Colognato R.","year":"2012","unstructured":"Colognato R.; Park M.V.D.Z.; Wick P.; De Jong W.H.; Advers Eff Eng Nanomater 2012,3-24","journal-title":"Advers Eff Eng Nanomater"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1021\/acsomega.6b00141","volume":"1","author":"Lomel\u00ed-Rosales D.A.","year":"2016","unstructured":"Lomel\u00ed-Rosales D.A.; Rangel-Salas I.I.; Zamudio-Ojeda A.; Carbajal-Ar\u00edzaga G.G.; Godoy-Alc\u00e1ntar C.; Manr\u00edquez-Gonz\u00e1lez R.; Alvarado-Rodr\u00edguez J.G.; Mart\u00ednez-Otero D.; Cortes-Llamas S.A.; Chiral imidazolium-functionalized Au nanoparticles: reversible aggregation and molecular recognition. ACS Omega 2016,1(5),876-885","journal-title":"ACS Omega"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.biomaterials.2007.12.037","volume":"29","author":"De Jong W.H.","year":"2008","unstructured":"De Jong W.H.; Hagens W.I.; Krystek P.; Burger M.C.; Sips A.J.A.M.; Geertsma R.E.; Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008,29(12),1912-1919","journal-title":"Biomaterials"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1042\/BST0340330","volume":"34","author":"Loenen W.A.M.","year":"2006","unstructured":"Loenen W.A.M.; S-adenosylmethionine: jack of all trades and master of everything? Biochem Soc Trans 2006,34(Pt 2),330-333","journal-title":"Biochem Soc Trans"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"10257","DOI":"10.1021\/jm501100b","volume":"57","author":"Vitaku E.","year":"2014","unstructured":"Vitaku E.; Smith D.T.; Njardarson J.T.; Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J Med Chem 2014,57(24),10257-10274","journal-title":"J Med Chem"},{"key":"ref=8","first-page":"268","volume":"3","author":"Bhatnagar A.","year":"2011","unstructured":"Bhatnagar A.; Sharma P.; Kumar N.; A review on \u201cImidazoles\u201d: their chemistry and pharmacological potentials. Int J Pharm Tech Res 2011,3(1),268-282","journal-title":"Int J Pharm Tech Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1039\/C4MD00277F","volume":"5","author":"Sharma G.V.M.","year":"2014","unstructured":"Sharma G.V.M.; Ramesh A.; Singh A.; Srikanth G.; Jayaram V.; Duscharla D.; Jun J.H.; Ummanni R.; Malhotra S.V.; MedChemComm 2014,5(11),1751-1760","journal-title":"MedChemComm"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/S0968-0896(99)00160-1","volume":"7","author":"Wachall B.G.","year":"1999","unstructured":"Wachall B.G.; Hector M.; Zhuang Y.; Hartmann R.W.; Imidazole substituted biphenyls: a new class of highly potent and in vivo active inhibitors of P450 17 as potential therapeutics for treatment of prostate cancer. Bioorg Med Chem 1999,7(9),1913-1924","journal-title":"Bioorg Med Chem"},{"key":"ref=11","author":"Tabuteau H.","year":"2014","unstructured":"Tabuteau H.; Substituted Imidazolium Compounds For Treating Disease Patent US 8,901,162 B1 2014"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.poly.2014.07.014","volume":"81","author":"Reynoso-Esparza M.A.","year":"2014","unstructured":"Reynoso-Esparza M.A.; Rangel-Salas I.I.; Peregrina-Lucano A.A.; Alvarado-Rodr\u00edguez J.G.; L\u00f3pez-Dellamary-Toral F.A.; Manr\u00edquez-Gonz\u00e1lez R.; Espinosa-Mac\u00edas M.L.; Cortes-Llamas S.A.; Polyhedron 2014,81,564-571","journal-title":"Polyhedron"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","volume":"32","author":"Lu S.C.","year":"2000","unstructured":"Lu S.C.; S-Adenosylmethionine. Int J Biochem Cell Biol 2000,32(4),391-395","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=14","first-page":"2587","volume":"22","author":"Qui\u00f1onez-L\u00f3pez R.R.","year":"2018","unstructured":"Qui\u00f1onez-L\u00f3pez R.R.; Rangel-Salas I.I.; Estrada-Flores J.R.; Cortes-Llamas S.A.; Chiral imidazolium salts derived from amino acids: synthesis characterization and structure. Curr Org Chem 2018,22,2587-2595","journal-title":"Curr Org Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1472-6882-10-61","volume":"10","author":"Preza A.M.","year":"2010","unstructured":"Preza A.M.; Jaramillo M.E.; Puebla A.M.; Mateos J.C.; Hern\u00e1ndez R.; Lugo E.; Antitumor activity against murine lymphoma L5178Y model of proteins from cacao (Theobroma cacao L.) seeds in relation with in vitro antioxidant activity. BMC Complement Altern Med 2010,10(1),61-72","journal-title":"BMC Complement Altern Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/jmf.2009.0103","volume":"14","author":"Jaramillo-Flores M.E.","year":"2011","unstructured":"Jaramillo-Flores M.E.; Heriyati-Permady H.; Puebla-Perez A.M.; Padilla E.; Lugo-Cervantes E.C.; Delgado-Saucedo J.I.; Ramon-Gallegos E.; Effect of ditaxin and heteranthin and inhibitory effect of Ditaxis heterantha extract on L5178Y tumor development in mice. J Med Food 2011,14(5),462-467","journal-title":"J Med Food"},{"key":"ref=17","first-page":"4736","volume":"43","author":"Beer J.Z.","year":"1983","unstructured":"Beer J.Z.; Budzicka E.; Niepokojczycka E.; Rosiek O.; Szumiel I.; Walicka M.; Loss of tumorigenicity with simultaneous changes in radiosensitivity and photosensitivity during in vitro growth of L5178Y murine lymphoma cells. Cancer Res 1983,43(10),4736-4742","journal-title":"Cancer Res"},{"key":"ref=18","first-page":"128","volume":"30","author":"Reynoso-Orozco R.","year":"2008","unstructured":"Reynoso-Orozco R.; Delgado-Saucedo J.I.; Puebla-P\u00e9rez A.M.; Calvo-M\u00e9ndez C.; Carr D.; Vel\u00e1zquez-Maga\u00f1a S.; Santerre A.; Rev Salud Anim 2008,30(2),128-132","journal-title":"Rev Salud Anim"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1734-1140(13)71086-7","volume":"65","author":"Wojnicki M.","year":"2013","unstructured":"Wojnicki M.; Luty-B\u0142ocho M.; Bednarski M.; Dudek M.; Knutelska J.; Sapa J.; Zygmunt M.; Nowak G.; Fitzner K.; Tissue distribution of gold nanoparticles after single intravenous administration in mice. Pharmacol Rep 2013,65(4),1033-1038","journal-title":"Pharmacol Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.colsurfb.2008.07.004","volume":"66","author":"Sonavane G.","year":"2008","unstructured":"Sonavane G.; Tomoda K.; Makino K.; Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 2008,66(2),274-280","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2071\"","DOI":"10.2147\/IJN.S21657","volume":"6","author":"Zhang X.D.","year":"2011","unstructured":"Zhang X.D.; Wu D.; Shen X.; Liu P.X.; Yang N.; Zhao B.; Zhang H.; Sun Y.M.; Zhang L.A.; Fan F.Y.; Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int. J. Nanomed. 2011,6,2071\"-2081"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2147\/IJN.S8428.","volume":"5","author":"Zhang X.D.","year":"2010","unstructured":"Zhang X.D.; Wu H.Y.; Wu D.; Wang Y.Y.; Chang J.H.; Zhai Z.B.; Meng A.M.; Liu P.X.; Zhang L.A.; Fan F.Y.; Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomed. 2010,5,771-781"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00003495-198530040-00003","volume":"30","author":"Williams K.","year":"1985","unstructured":"Williams K.; Lee E.; Importance of drug enantiomers in clinical pharmacology. Drugs 1985,30(4),333-354","journal-title":"Drugs"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2006.2085","volume":"2","author":"Nguyen L.A.","year":"2006","unstructured":"Nguyen L.A.; He H.; Pham-Huy C.; Chiral drugs: an overview. Int J Biomed Sci 2006,2(2),85-100","journal-title":"Int J Biomed Sci"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177206","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/177206\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/177206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T06:58:14Z","timestamp":1722149894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177206\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406415666191206093754","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}